FOXO3 deficiency has been confirmed to play an important role in regulating lung inflammation of COPD/emphysema, which has emerged as a new approach to address the development of pulmonary inflammatory diseases (Hwang et al., 2011). The gene discussed is FOXO3; the disease is chronic obstructive pulmonary disease.